SAMSUNG SEOUL HOSPITAL ACHIEVES THE HIGHEST NUMBER OF HYBRID TREATMENT CASES IN SOUTH KOREA FOR PULMONARY HYPERTENSION DUE TO CHRONIC THROMBOEMBOLIC DISEASE.
21 March, 2023
The Pulmonary Hypertension Center at Samsung Seoul Hospital announced that it achieved 300 cases as of June 2022, following South Korea’s first successful percutaneous balloon pulmonary artery dilation for pulmonary hypertension due to chronic thromboembolic disease in 2015. Additionally, 100 cases of pulmonary thromboendarterectomy have been performed since the establishment of the center, achieving the […]